Related Experiment Video
Updated: May 22, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Mild cognitive impairment: statistical models of transition using longitudinal clinical data
Erin L Abner1, Richard J Kryscio, Gregory E Cooper
1Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA.
Abstract:
Mild cognitive impairment (MCI) refers to the clinical state between normal cognition and probable Alzheimer's disease (AD), but persons diagnosed with MCI may progress to non-AD forms of dementia, remain MCI until death, or recover to normal cognition. Risk factors for these various clinical changes, which we term "transitions," may provide targets for therapeutic interventions. Therefore, it is useful to develop new approaches to assess risk factors for these transitions. Markov models have been used to investigate the transient nature of MCI represented by amnestic single-domain and mixed MCI states, where mixed MCI comprised all other MCI subtypes based on cognitive assessments. The purpose of this study is to expand this risk model by including a clinically determined MCI state as an outcome. Analyses show that several common risk factors play different roles in affecting transitions to MCI and dementia. Notably, APOE-4 increases the risk of transition to clinical MCI but does not affect the risk for a final transition to dementia, and baseline hypertension decreases the risk of transition to dementia from clinical MCI.
Insights
Understanding transitions from mild cognitive impairment (MCI) is key. Risk factors like APOE-4 influence MCI development, while hypertension impacts dementia progression from MCI.
Area of Science:
- Neurology
- Gerontology
- Biostatistics
Background:
- Mild cognitive impairment (MCI) represents a transitional state between normal cognition and Alzheimer's disease (AD).
- Individuals with MCI exhibit diverse clinical trajectories, including progression to dementia, persistent MCI, or recovery to normal cognition.
- Identifying risk factors for these transitions is crucial for developing targeted therapeutic interventions.
Purpose of the Study:
- To expand existing risk models for MCI transitions by incorporating a clinically determined MCI state as an outcome.
- To investigate the differential roles of common risk factors in transitions to MCI and dementia.
Main Methods:
- Utilized Markov models to analyze the transient nature of MCI states (amnestic single-domain and mixed MCI).
- Incorporated a clinically determined MCI state as a key outcome in the risk assessment model.
Main Results:
- Common risk factors demonstrate varied effects on transitions to MCI versus dementia.
- The APOE-4 allele increases the risk of transitioning to clinical MCI but does not influence the final transition to dementia.
- Baseline hypertension was found to decrease the risk of dementia progression from clinical MCI.
Conclusions:
- Risk factor profiles differ for progression to MCI and subsequent dementia.
- Understanding these distinct risk factor roles is essential for refining prognostic models and therapeutic strategies for cognitive decline.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Related Concept Videos
Cognitive Development During Adulthood
Alzheimer Disease l: Introduction
Dementia l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Longitudinal Studies